Team

Fengyi is currently a Bioengineering MS student working on the LNP-associated inflammation (LAI) project. His research focuses on identifying key pathways responsible for LAI and optimizing inhibitors to improve the safety and efficacy of LNPs. He will be  pursuing a PhD at the University of Oklahoma starting January 2026.